Researcher uncovers treatment for E.coli

Oct 29, 2008

(PhysOrg.com) -- It couldn't be more ironic. Just as the number of people in North Bay, Ont., made ill by a recent E.coli outbreak, topped 200, a University of Alberta professor has announced a breakthrough in development of a treatment for the life-threatening bacteria.

Canada's worst E.coli breakout was in Walkerton, Ont. in 2000, when seven people died and more than 20 children suffered permanent kidney damage. But chemistry professor David Bundle and his co-workers may have found a way to protect the kidneys.

"If you give [the patient] antibiotics the bacteria die and burst open, spilling their toxins," said Bundle, cautioning that if the E. coli toxin invades the kidney, the result can be fatal.

But Bundle and his colleagues-Pavel Kitov and Glen Armstrong-have created a drug that lashes the E.coli bacteria to a naturally-occurring protein molecule, preventing the E.coli from making contact with kidney cells.

The drug that acts like a lasso is called Polybait.

"Think of Polybait as piece of sticky string that wraps around the interface between the protein and the toxin," he said. "The surface of the toxin that kills kidney cells is drawn tightly against the surface of the protein and neutralizes it."

The molecules are held together long enough to be transported to the liver and eventually eliminated from the body.

Testing is in the early stages but so far the drug looks promising. One hundred per cent of the lab mice injected with E.coli toxin were saved by Polybait, although Bundle says that doesn't mean the big pharmaceutical companies will come running. The number of E.coli outbreaks and the relatively small number of victims will not draw a lot of investment dollars, he says, so to generate more interest Bundle and his team is trying to develop more uses for Polybait.

"We want to go beyond neutralizing bacteria to targeting specific cancer cells," he said, and that the team is working with the Scribbs Research Institute in the United States to do just that.

In the meantime Bundle and his group are hopeful that someday their E.coli treatment will be of help to people in places like North Bay and Walkerton.

"From a social perspective and also from a perspective of what it costs society to have people on kidney dialysis for long periods of time, this research is worthwhile."

Provided by University of Alberta

Explore further: UN Ebola head warns against complacency as fight enters last lap

Related Stories

Italian olive tree disease stumps EU

8 hours ago

EU member states are divided on how to stop the spread of a disease affecting olive trees in Italy that could result in around a million being cut down, officials said Friday.

Festo has BionicANTs communicating by the rules for tasks

8 hours ago

Germany-based automation company Festo, focused on technologies for tasks, turns to nature for inspiration, trying to take the cues from how nature performs tasks so efficiently. "Whether it's energy efficiency, ...

Jury decides Silicon Valley firm did not discriminate

8 hours ago

A jury decided Friday that a prestigious venture capital firm did not discriminate or retaliate against a female employee in a case that shined a light on gender imbalance and working conditions for women ...

Intel in talks with Altera on tie-up

8 hours ago

US tech giant Intel is in talks with rival Altera on a tie-up to broaden the chipmaker's product line amid growth in Internet-connected devices, the Wall Street Journal reported Friday.

Recommended for you

Sierra Leone ends anti-Ebola lockdown after three days

24 minutes ago

Sierra Leoneans were once again allowed to leave their homes Sunday evening after the government announced the end of a three-day nationwide lockdown aimed at preventing a resurgence of the deadly Ebola virus.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.